$1.25
-3.5%Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Strong working capital position provides significant operational flexibility and financial cushion.
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Mixed signals: Strong short-term liquidity provides comfort, but high overall leverage requires careful monitoring of debt servicing capabilities and refinancing risk.
SLSN • NASDAQ
| Solesence, Inc. Common Stock Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
ASSETS | |||||
CURRENT ASSETS | |||||
1.3M | 1.4M | 1.7M | 2.2M | 657K | |
1.3M | 1.4M | 1.7M | 2.2M | 657K | |
6.8M | 4.9M | 3.5M | 4.7M | 3.9M | |
6.8M | 4.9M | 3.5M | 4.7M | 3.9M | |
18.5M | 20.3M | 10M | 8.8M | 6.1M | |
0.0 | 0.0 | 0.0 | 0.0 | 910K | |
2.1M | 2.8M | 1.1M | 866K | 0.0 | |
28.8M | 29.3M | 16.3M | 16.6M | 11.6M | |
NON-CURRENT ASSETS | |||||
6.9M | 20.7M | 16.6M | 16.9M | 16.8M | |
14.4M | 3K | 4K | 6K | 8K | |
21.3M | 20.7M | 16.6M | 16.9M | 16.8M | |
50.1M | 50M | 32.9M | 33.6M | 28.4M | |
LIABILITIES | |||||
CURRENT LIABILITIES | |||||
4.4M | 10.7M | 6.4M | 6.8M | 3.9M | |
4.4M | 10.7M | 6.4M | 6.8M | 3.9M | |
2.6M | 3.3M | 741K | 559K | 504K | |
4.8M | 5M | 4.8M | 4.3M | 1.4M | |
1.3M | 1.3M | 1.3M | 0.0 | 694K | |
930K | 5.6M | 2.4M | 2.2M | 905K | |
13.9M | 25.8M | 15.6M | 13.8M | 7.3M | |
NON-CURRENT LIABILITIES | |||||
10.5M | 0.0 | 6M | 4M | 1M | |
0.0 | 0.0 | 0.0 | 21K | 661K | |
194K | 246K | 238K | 230K | 222K | |
18.5M | 9.3M | 15.4M | 14.1M | 13.6M | |
9.1M | 10.3M | 10.4M | 9.8M | 12.4M | |
32.4M | 35.1M | 31M | 27.9M | 20.9M | |
SHAREHOLDERS' EQUITY | |||||
706K | 700K | 496K | 493K | 489K | |
115.6M | 114.7M | 106.1M | 105.2M | 104.4M | |
-98.6M | -100.4M | -104.7M | -100.1M | -97.4M | |
17.6M | 14.9M | 1.9M | 5.6M | 7.5M | |
17.6M | 14.9M | 1.9M | 5.6M | 7.5M | |
SUMMARY | |||||
50.1M | 50M | 32.9M | 33.6M | 28.4M | |
24.3M | 15.3M | 21.3M | 18.1M | 14.8M | |
23M | 13.9M | 19.5M | 15.9M | 14.1M | |
70,481,945 | 70,481,945 | 70,481,945 | 70,481,945 | 70,481,945 |
SLSN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 12, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 12, 2026 | May 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 24, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 23, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 31, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 03, 2025 | November 24, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 01, 2025 | November 21, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 11, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 |
Continue your SLSN research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.